ロード中...
Development of skin hypopigmentation in a patient with metastatic papillary carcinoma thyroid treated with Sorafenib
BACKGROUND: Sorafenib can be considered as the effective option of treatment in patients with metastatic radioiodine refractory differentiated thyroid cancers. The cutaneous manifestations of Sorafenib include rash, desquamation, hand foot skin reactions, pruritus, alopecia and erythema. We report t...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3750499/ https://ncbi.nlm.nih.gov/pubmed/23937803 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6823-13-29 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|